Skip to main navigation Skip to search Skip to main content

Difficult to treat Pseudomonas: successful salvage therapy with cefepime-zidebactam

Research output: Contribution to journalArticlepeer-review

Abstract

Carbapenem-resistant Pseudomonas aeruginosa (CRPa) infection is extremely challenging to manage. Cefepime-zidebactam is a novel combination that can be considered for salvage therapy when no other antimicrobials are susceptible. A 15-y-old boy presented with 56% thermal burns, followed by skin and soft tissue infection, secondary bacteraemia, complicated parapneumonic effusion and endophthalmitis due to CRPa, which was not susceptible to any of the routinely available antibiotics. He was treated with cefepime-zidebactam for 45 d, with which he recovered.

Original languageEnglish
Pages (from-to)632-634
Number of pages3
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene
Volume118
Issue number9
DOIs
Publication statusPublished - 01-09-2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Parasitology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Difficult to treat Pseudomonas: successful salvage therapy with cefepime-zidebactam'. Together they form a unique fingerprint.

Cite this